Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.2M | Hold |
218,000
| – | – | 0.01% | 672 |
|
|
2025
Q4 | $60M | Sell |
218,000
-500
| -0.2% | -$140K | 0.01% | 695 |
|
|
2025
Q3 | $63M | Buy |
+218,500
| New | +$64.7M | 0.01% | 665 |
|
|
2024
Q3 | – | Sell |
-100
| Closed | -$33.1K | – | 5314 |
|
|
2024
Q2 | $33.1K | Buy |
+100
| New | +$34.5K | ﹤0.01% | 4341 |
|
|
2022
Q1 | – | Sell |
-9,900
| Closed | -$2.27M | – | 5012 |
|
|
2021
Q4 | $2.27M | Buy |
+9,900
| New | +$2.1M | ﹤0.01% | 2306 |
|
|
2021
Q2 | – | Sell |
-1,300
| Closed | -$314K | – | 4888 |
|
|
2021
Q1 | $314K | Sell |
1,300
-18,496
| -93% | -$4.12M | ﹤0.01% | 3477 |
|
|
2020
Q4 | $4.12M | Hold |
19,796
| – | – | ﹤0.01% | 1650 |
|
|
2020
Q3 | $3.35M | Hold |
19,796
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q2 | $3.71M | Sell |
19,796
-95,200
| -83% | -$18.1M | ﹤0.01% | 1595 |
|
|
2020
Q1 | $20.4M | Buy |
114,996
+16,900
| +17% | +$3.28M | 0.02% | 632 |
|
|
2019
Q4 | $20.1M | Sell |
98,096
-11,800
| -11% | -$2.16M | 0.01% | 950 |
|
|
2019
Q3 | $16.7M | Buy |
109,896
+14,984
| +16% | +$2.44M | 0.01% | 988 |
|
|
2019
Q2 | $15M | Buy |
94,912
+33,296
| +54% | +$5.22M | 0.01% | 1101 |
|
|
2019
Q1 | $9.91M | Buy |
61,616
+8,160
| +15% | +$1.49M | 0.01% | 1230 |
|
|
2018
Q4 | $10.2M | Buy |
53,456
+256
| +0.5% | +$53.4K | 0.01% | 1150 |
|
|
2018
Q3 | $11.1M | Sell |
53,200
-162,700
| -75% | -$30.2M | 0.01% | 1201 |
|
|
2018
Q2 | $36.7M | Sell |
215,900
-32,100
| -13% | -$5.56M | 0.03% | 477 |
|
|
2018
Q1 | $41.6M | Buy |
248,000
+214,900
| +649% | +$41.8M | 0.03% | 490 |
|
|
2017
Q4 | $6.72M | Buy |
33,100
+8,700
| +36% | +$1.73M | 0.01% | 1443 |
|
|
2017
Q3 | $4.56M | Sell |
24,400
-20,500
| -46% | -$3.65M | ﹤0.01% | 1608 |
|
|
2017
Q2 | $7.52M | Buy |
44,900
+14,100
| +46% | +$2.27M | 0.01% | 1170 |
|
|
2017
Q1 | $4.51M | Sell |
30,800
-4,700
| -13% | -$693K | ﹤0.01% | 1400 |
|
|
2016
Q4 | $4.74M | Buy |
35,500
+17,200
| +94% | +$2.25M | 0.01% | 1414 |
|
|
2016
Q3 | $2.38M | Buy |
18,300
+2,200
| +14% | +$287K | ﹤0.01% | 1852 |
|
|
2016
Q2 | $2.06M | Sell |
16,100
-1,000
| -6% | -$132K | ﹤0.01% | 1982 |
|
|
2016
Q1 | $2.34M | Sell |
17,100
-180,400
| -91% | -$24.8M | ﹤0.01% | 1778 |
|
|
2015
Q4 | $28.8M | Buy |
197,500
+44,500
| +29% | +$6.12M | 0.04% | 435 |
|
|
2015
Q3 | $20.7M | Buy |
153,000
+62,700
| +69% | +$9.1M | 0.02% | 586 |
|
|
2015
Q2 | $14.6M | Buy |
90,300
+52,500
| +139% | +$7.25M | 0.02% | 817 |
|
|
2015
Q1 | $4.88M | Sell |
37,800
-17,000
| -31% | -$1.98M | 0.01% | 1579 |
|
|
2014
Q4 | $5.59M | Sell |
54,800
-18,400
| -25% | -$1.81M | 0.01% | 1609 |
|
|
2014
Q3 | $6.59M | Buy |
73,200
+22,600
| +45% | +$2.11M | 0.01% | 1526 |
|
|
2014
Q2 | $4.61M | Buy |
50,600
+700
| +1% | +$60K | ﹤0.01% | 1819 |
|
|
2014
Q1 | $4.14M | Sell |
49,900
-56,800
| -53% | -$4.68M | ﹤0.01% | 1855 |
|
|
2013
Q4 | $9.28M | Buy |
106,700
+77,800
| +269% | +$6.36M | 0.01% | 1311 |
|
|
2013
Q3 | $2.2M | Sell |
28,900
-289,300
| -91% | -$22.6M | ﹤0.01% | 2460 |
|
|
2013
Q2 | $23.1M | Buy |
+318,200
| New | +$21.4M | 0.03% | 579 |
|
Other funds holding CI
VCM
VPM
Barclays's CI Position: Q1 2026 in Review
Barclays increased its Cigna (CI) stake by 46% in Q1 2026, buying an estimated $66.1M and bringing the position to 758,643 shares worth $202M. The position accounts for 0.05% of the portfolio, ranked #293.
Barclays first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $371M in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Barclays held 758,643 shares of Cigna worth $202M as of Q1 2026.
- Barclays bought 238,727 Cigna shares in Q1 2026, an estimated $66.1M.
- Cigna made up 0.05% of Barclays's portfolio in Q1 2026, its #293 holding.
- Barclays first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
- Barclays's Cigna position peaked at $371M in Q1 2024.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.